Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines
Jason I. Couto(The Ohio State University), Cheryl A. London(The Ohio State University)
Cited by 26
Related Papers
Characterization of STAT3 activation and expression in canine and human osteosarcoma
|BMC Cancer|2009|114
Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines
|BMC Cancer|2011|111
The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines
|BMC Cancer|2011|92
Phase I Evaluation of STA-1474, a Prodrug of the Novel HSP90 Inhibitor Ganetespib, in Dogs with Spontaneous Cancer
|PLoS ONE|2011|51
Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma
|BMC Veterinary Research|2015|34